EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapy






Head & Neck 36(7): 923-933

Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapy

Treatment of oropharyngeal cancer with transoral robotic surgery (TORS) or definitive (chemo)radiotherapy impacts quality of life. Utility scores are needed for quality of life and economic comparisons. Fifty healthy subjects and 9 experts reviewed scenarios describing treatment (TORS alone or with adjuvant radiotherapy or chemoradiotherapy [CRT], definitive radiotherapy, and CRT), complications, remission, and recurrences. Utilities were assessed using visual analog scale (VAS) and standard gamble (SG) techniques. Treatments were compared using paired comparisons and demographic variability was assessed. TORS had higher SG utilities than radiotherapy (p = .001) and CRT (p < .001) and was preferred in paired comparisons (p < .001 for both) for healthy subjects. Utilities did not vary by demographic group and correlated between experts and subjects (VAS r = 0.95; p < .001; SG r = 0.97; p < .001). TORS has higher utility scores than CRT. Utilities can be used for cost-utility analyses.


Accession: 055116472

PMID: 23595774

DOI: 10.1002/hed.23340



Related references

de Almeida, J.R.; Moskowitz, A.J.; Miles, B.A.; Goldstein, D.P.; Teng, M.S.; Sikora, A.G.; Gupta, V.; Posner, M.; Genden, E.M., 2014: Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis. The present study is an economic evaluation comparing transoral robotic surgery (TORS) to (chemo)radiotherapy for the management of early T-classification oropharyngeal cancer. A societal perspective was adopted. Treatment for TORS and (chemo)radi...

Ling, D.C.; Chapman, B.V.; Kim, J.; Choby, G.W.; Kabolizadeh, P.; Clump, D.A.; Ferris, R.L.; Kim, S.; Beriwal, S.; Heron, D.E.; Duvvuri, U., 2016: Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. It has been postulated that treatment outcomes are similar between transoral robotic surgery (TORS) and definitive chemoradiation (CRT) for oropharyngeal squamous cell carcinomas (OPSCC). We compared oncologic and quality of life (QOL) outcomes be...

Krishnan, S.Giridhar.Suren.; Umapathysivam, K.; Lockwood, C.; Hodge, J-Charles., 2016: Oncological and survival outcomes following transoral robotic surgery versus transoral laser microsurgery for the treatment of oropharyngeal squamous cell carcinoma: a systematic review protocol. The objective of this systematic review is to synthesize the best available evidence regarding the oncological and survival outcomes (as measured by disease control, disease-free survival, disease-specific survival and overall survival) of transor...

Chung, T.K.; Rosenthal, E.L.; Magnuson, J.Scott.; Carroll, W.R., 2015: Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. To compare the clinical and cost outcomes of transoral robotic surgery (TORS) versus open procedures following the U.S. Food and Drug Administration approval in December 2009. Retrospective analysis of the Nationwide Inpatient Sample from 2008 to...

Smith, R.V.; Schiff, B.A.; Garg, M.; Haigentz, M., 2016: The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients. To assess adjuvant therapy in patients undergoing surgical management of oropharyngeal squamous cell carcinoma (OPSCCA) with transoral robotic surgery (TORS) and neck dissection. A prospective, nonrandomized, consecutive patient series from two se...

Sumer, B.D.; Goyal, V.; Truelson, J.M.; Myers, L.L., 2013: Transoral robotic surgery and transoral laser microsurgery for oropharyngeal squamous cell cancer. The aim of our study was to compare transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) for primary resection of oropharyngeal squamous cell cancer (OPSCC). This was a retrospective chart analysis of 33 patients with OPSCC trea...

Lörincz, B.B.; Möckelmann, N.; Busch, C-Jung.; Knecht, R., 2016: Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma. This is a single-institution prospective study in a tertiary care center to evaluate feasibility, completeness of resection, and functional outcomes for oropharyngeal squamous cell carcinoma (SCC) treated primarily with transoral robotic-assisted...

Sadeghi, N.; Li, N-Wei.; Taheri, M.Reza.; Easley, S.; Siegel, R.S., 2016: Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach. The purpose of this study was to present our evaluation of the outcome of oropharyngeal cancer managed with neoadjuvant chemotherapy and transoral surgery (TOS) with neck dissection as definitive treatment. This is a case series of 17 patients wit...

Sher, D.J.; Fidler, M.Jo.; Tishler, R.B.; Stenson, K.; al-Khudari, S., 2016: Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer. To perform a cost-effectiveness analysis of primary chemoradiation therapy (CRT) versus transoral robotic surgery (TORS) for clinical N2, human papillomavirus (HPV)-positive oropharyngeal carcinoma. We developed a Markov model to describe the heal...

Foote, R.L.; Garces, Y.I.; Neben Wittich, M.A.; Ma, D.J.; Park, S.S.; Molina, J.R.; Okuno, S.H.; Price, K.A.; Schild, S.E.; Patel, S.H., 2013: Oropharyngeal cancer biology and treatment: insights from messenger RNA sequence analysis and transoral robotic surgery. Mayo Clinic Proceedings 87(11): 1132; Author Reply 1132-3